Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu-city, Gifu, Japan.
J Neurosurg. 2013 May;118(5):1003-8. doi: 10.3171/2012.11.JNS12610. Epub 2012 Dec 14.
Hematoma growth unrelated to aneurysmal rebleeding is recognized as a somewhat common complication following endovascular embolization of ruptured aneurysms, but it is scarcely studied. The aim of this study is to elucidate the possible risk factors for this phenomenon.
Included in this study were 101 consecutive patients with subarachnoid hemorrhage (SAH) who underwent endovascular embolization for saccular aneurysms at the authors' institution within 72 hours of symptom onset. All endovascular procedures were conducted under intraprocedural systemic anticoagulation. Age, sex, hypertension, type 2 diabetes, preoperative antiplatelet or anticoagulation use, neurological grade, Fisher grade, location and size of the aneurysm, grade of aneurysm occlusion, and timing of the endovascular procedure were retrospectively analyzed to determine the risk factors for hematoma growth unrelated to aneurysmal rebleeding. To determine the clinical significance of this complication, the authors also investigated the risk factors for poor clinical outcome (modified Rankin Scale Scores 3-6 at 30 days after onset).
This series included 32 men (31.7%) and 69 women (68.3%) with a mean age ± SD of 65.5 ± 14.0 years. The mean time from onset to endovascular procedure was 12.1 ± 14.0 hours. After the procedure, hematoma growth unrelated to aneurysmal rebleeding occurred in 14 patients (13.9%), 10 of whom required surgical removal of the hematoma and/or ventriculostomy to control intracranial pressure. All 14 patients had an anterior circulation aneurysm and had Fisher Grade 3 or 4 SAH. Ultra-early embolization (conducted within 6 hours after onset), female sex, history of hypertension, and poor neurological grade (World Federation of Neurosurgical Societies Grades IV and V) were significant risk factors for hematoma growth (p < 0.05 for all, univariate logistic analysis). In multivariate analysis, ultra-early embolization (OR 18.0 [95% CI 3.26-338], p < 0.001) and female sex (OR 9.83 [95% CI 1.73-187], p = 0.007) were independent risk factors for this phenomenon. Anterior circulation aneurysms and Fisher Grade 3 or 4 SAH were also revealed to be significant risk factors (p = 0.02 for each, chi-square test). Furthermore, hematoma growth without aneurysmal rebleeding was determined as an independent risk factor for poor clinical outcome by multivariate logistic analysis (OR 11.8 [95% CI 2.31-87.1], p = 0.002).
Ultra-early endovascular embolization for ruptured cerebral aneurysms under systemic anticoagulation increases the risk of growth of hematomas unrelated to aneurysmal rebleeding. It is important to recognize the risk of this complication and to either reduce the amount of heparin or to refer the patient for direct clipping if appropriate.
血管内栓塞破裂动脉瘤后,血肿增大与动脉瘤再出血无关,这被认为是一种较为常见的并发症,但目前对此研究甚少。本研究旨在阐明该现象的可能危险因素。
本研究纳入了 101 例在症状发作后 72 小时内在作者所在机构接受血管内栓塞治疗的蛛网膜下腔出血(SAH)患者。所有血管内手术均在术中全身抗凝下进行。回顾性分析年龄、性别、高血压、2 型糖尿病、术前抗血小板或抗凝药物使用、神经功能分级、Fisher 分级、动脉瘤位置和大小、动脉瘤闭塞程度以及血管内手术时机等因素,以确定与动脉瘤再出血无关的血肿增大的危险因素。为了确定该并发症的临床意义,作者还研究了与不良临床结局(发病后 30 天改良 Rankin 量表评分 3-6 分)相关的危险因素。
本系列研究包括 32 名男性(31.7%)和 69 名女性(68.3%),平均年龄±标准差为 65.5±14.0 岁。从发病到血管内手术的平均时间为 12.1±14.0 小时。术后 14 例患者发生与动脉瘤再出血无关的血肿增大,其中 10 例需要开颅清除血肿和/或脑室造口以控制颅内压。所有 14 例患者均为前循环动脉瘤,Fisher 分级 3 或 4 级 SAH。超早期栓塞(发病后 6 小时内进行)、女性、高血压病史和较差的神经功能分级(世界神经外科学会联合会分级 IV 级和 V 级)是血肿增大的显著危险因素(所有因素 p<0.05,单因素逻辑分析)。多因素分析显示,超早期栓塞(OR 18.0[95%CI 3.26-338],p<0.001)和女性(OR 9.83[95%CI 1.73-187],p=0.007)是该现象的独立危险因素。前循环动脉瘤和 Fisher 分级 3 或 4 级 SAH 也被确定为显著危险因素(卡方检验,p=0.02)。此外,多因素逻辑分析显示,血肿无动脉瘤再出血增大是不良临床结局的独立危险因素(OR 11.8[95%CI 2.31-87.1],p=0.002)。
在全身抗凝下对破裂脑动脉瘤进行超早期血管内栓塞会增加与动脉瘤再出血无关的血肿增大的风险。认识到这种并发症的风险很重要,如果肝素剂量需要减少或适当直接夹闭,应参考患者的情况。